Skip to content

CACIPLIQ20

by Organes Tissus Regeneration Reparation Remplacement 3 variants

Ref Q751Model CACIPLIQ20 Spray

Active European Union

CE MDD

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-03770022450004 Basic UDI-DI 03770022450004UDI-DIDate18 Nov 2021RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD Active

Specification

EUDAMED

Model / Reference
CACIPLIQ20 Spray, Q751
Primary DI / UDI-DI
03770022450004
Basic UDI-DI
B-03770022450004
EMDN Code
M040499 Dressings for wounds, sores and ulcerations - other
Device Class
Class III
EU market of registration
France

Manufacturer details

EUDAMED SRN
FR-MF-000009099

Related devices

Category: Negative-pressure wound therapy system foam dressing, non-antimicrobial

Other devices from Organes Tissus Regeneration Reparation Remplacement

Properties

  • Sterile

Other properties (10)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No